生命科学资讯

UniQure says FDA prefers randomized trial for Huntington's treatment

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 34.15% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews

Thermo Fisher Scientific Inc. $TMO Stock Holdings Increased by Fisher Asset Management LLC - MarketBeat

Aardvark pauses phase 3 metabolic drug study over 'cardiac observations,' sinking sock

Roche reports another phase 3 multiple sclerosis win, but deaths add to safety questions

Quantbot Technologies LP Takes $4.23 Million Position in Waters Corporation $WAT - MarketBeat

Roche reports pivotal MS win, but deaths add to safety questions - Fierce Biotech

Mitsubishi UFJ Asset Management Co. Ltd. Grows Stake in Waters Corporation $WAT - MarketBeat

Why it’s critical to close open steps in cell therapy manufacturing

Davis R M Inc. Sells 2,494 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

Citigroup Inc. Sells 24,449 Shares of Waters Corporation $WAT - MarketBeat

Why Illumina (ILMN) Is Up 14.3% After Launching TruPath Genome And Expanding Rare-Disease Sequencing - Yahoo Finance

Inventerprise celebrates student winners in Bend - Central Oregon Daily

Raw signal segmentation for estimating RNA modification from Nanopore direct RNA sequencing data

JAX Animal Behavior System (JABS), a genetics-informed, end-to-end advanced behavioral phenotyping platform for the laboratory mouse

Agent-based modeling reveals how bats navigate dense group emergences

Resolving synaptic events using subsynaptically targeted GCaMP8 variants

A sense of direction

Agilent Technologies Inc.: Why This Lab-Tech Giant Is Suddenly on Every Trader’s Radar - AD HOC NEWS

10X Genomics Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo